APUS vs BB · $2.4M cap vs P/E 117, rev $549.1M
Apimeds Pharmaceuticals US, Inc. (APUS) versus BlackBerry Ltd (BB) — a side-by-side from cached financials, not a winner call.
Apimeds Pharmaceuticals US, Inc. (APUS) is a drug manufacturers - specialty & generic company listed on US.
BlackBerry Ltd (BB) is a software - infrastructure company listed on US.
APUS does not have a complete income-statement cache yet.
Latest reported BB revenue for 2026-02-28 was $549.1M. Net income was $53.2M. Revenue was up 2.7% from 2025-02-28 to 2026-02-28. BB currently screens at market cap $6.14B and trailing P/E 116.5.
APUS currently screens at market cap $2.4M. BB currently screens at market cap $6.14B and trailing P/E 116.5.
Not investment advice. Open the APUS and BB stock pages for the full models.
Not investment advice.